"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorn...

Ausführliche Beschreibung

Bibliographische Detailangaben

1. Verfasser:	Lipman, Frederick D. (VerfasserIn)
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Hoboken, NJ Wiley c2012
Schriftenreihe:	Wiley corporate F & A.
Schlagworte:	BUSINESS & ECONOMICS / Business Ethics Recht Wirtschaft Whistle blowing / United States Business ethics / United States Whistle blowing / Law and legislation / United States Whistle blowing / Case studies Whistleblowing USA Fallstudiensammlung
Online-Zugang:	FAB01 FRO01 Volltext
Zusammenfassung:	"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorneys for whistleblowers and defense attorneys as well as all potential employee whistleblowers. The book emphasizes the disincentives to whistleblowing, and will review the academic studies of whistleblowers with the idea of developing best practices to deal with whistleblowers: Introduction. 1. Dodd-Frank Incentives to Whistleblowers 2. The Remarkable Story of Cheryl Eckard and the $96 Million Bounty 3.The Pfizer Over $100 Million Bounty Collectors 4.Other Statutory Incentives to Whistleblowing 5.Disincentives to Whistleblowers and Academic Studies of Whistleblowers 6.Best Practices in Complying with the U. S. Department of Justice Guidelines 7.Best Practices for CEOs in Dealing with Whistleblowers 8.Best Practices for Conducting Whistleblower Investigations 9.The New SEC Whistleblower Rules 10.Qui Tam Actions and Their Defense "--
Beschreibung:	Front Matter -- Introduction -- The Whistleblowers and the Dodd b6 sFrank Incentives. The Dramatic Expansion of Whistleblower Awards under Dodd b6 sFrank -- The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act -- The Pfizer Whistleblowers who Collected Over $100 Million under the False Claims Act -- Disincentives and Factors Motivating Public Disclosure. Disincentives to Internal Whistleblowers -- Women as Whistleblowers: Factors Motivating Public Whistleblowing -- Organizational Best Practices. Why Should Organizations Adopt a Robust Whistleblower System? -- Establishing a Robust Whistleblower System -- Statutory Incentives and Sec Award Regulations. The False Claims Act: Qui Tam Cases -- IRS Whistleblowers -- Other Statutory Incentives and Protections for Whistleblowers -- A Step b6 sby b6 sStep Guide to SEC Whistleblowers Awards under Dodd b6 sFrank -- Appendix 1: IRS Form 211 -- Appendix 2: SEC Form TCR b7 sTip, Complaint or Referral -- Appendix 3: SEC Form WB-APP b7 sApplication for Award for Original Information Submitted Pursuant to Section 21F of the Securities Exchange Act of 1934 -- Appendix 4: SEC Whistleblower Rules -- About the Author -- Index Includes bibliographical references and index
Beschreibung:	1 Online-Ressource (xv, 272 S.)
ISBN:	111838654X 9781118386545